Titre : bêta-Tocophérol

bêta-Tocophérol : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "bêta-Tocophérol : Questions médicales les plus fréquentes", "headline": "bêta-Tocophérol : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les bêta-Tocophérol : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-31", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "bêta-Tocophérol" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tocophérols", "url": "https://questionsmedicales.fr/mesh/D024505", "about": { "@type": "MedicalCondition", "name": "Tocophérols", "code": { "@type": "MedicalCode", "code": "D024505", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.909.750" } } }, "about": { "@type": "MedicalCondition", "name": "bêta-Tocophérol", "alternateName": "beta-Tocopherol", "code": { "@type": "MedicalCode", "code": "D024503", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "John W Erdman", "url": "https://questionsmedicales.fr/author/John%20W%20Erdman", "affiliation": { "@type": "Organization", "name": "Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, IL." } }, { "@type": "Person", "name": "Morten Hostrup", "url": "https://questionsmedicales.fr/author/Morten%20Hostrup", "affiliation": { "@type": "Organization", "name": "The August Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark." } }, { "@type": "Person", "name": "Stephanie J Weinstein", "url": "https://questionsmedicales.fr/author/Stephanie%20J%20Weinstein", "affiliation": { "@type": "Organization", "name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA." } }, { "@type": "Person", "name": "Demetrius Albanes", "url": "https://questionsmedicales.fr/author/Demetrius%20Albanes", "affiliation": { "@type": "Organization", "name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. daa@nih.gov." } }, { "@type": "Person", "name": "Katherine M Ranard", "url": "https://questionsmedicales.fr/author/Katherine%20M%20Ranard", "affiliation": { "@type": "Organization", "name": "Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, IL." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A case-control study on immunologic markers of patients with vitiligo.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.113785" } }, { "@type": "ScholarlyArticle", "name": "Case-Control Study of Long COVID, Sapporo, Japan.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37044126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3201/eid2905.221349" } }, { "@type": "ScholarlyArticle", "name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37016998", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001192" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35875004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.913897" } }, { "@type": "ScholarlyArticle", "name": "Significance of temperature in antimuscarinic toxicity: a case-control study.", "datePublished": "2022-06-23", "url": "https://questionsmedicales.fr/article/35735006", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/15563650.2022.2088378" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzopyranes", "item": "https://questionsmedicales.fr/mesh/D001578" }, { "@type": "ListItem", "position": 6, "name": "Vitamine E", "item": "https://questionsmedicales.fr/mesh/D014810" }, { "@type": "ListItem", "position": 7, "name": "Tocophérols", "item": "https://questionsmedicales.fr/mesh/D024505" }, { "@type": "ListItem", "position": 8, "name": "bêta-Tocophérol", "item": "https://questionsmedicales.fr/mesh/D024503" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : bêta-Tocophérol - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur bêta-Tocophérol", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur bêta-Tocophérol", "description": "Comment diagnostiquer une carence en bêta-tocophérol ?\nQuels tests sont utilisés pour évaluer le bêta-tocophérol ?\nQuels symptômes indiquent un déficit en bêta-tocophérol ?\nLe bêta-tocophérol est-il mesuré dans les bilans de santé ?\nQuels médecins peuvent diagnostiquer une carence en bêta-tocophérol ?", "url": "https://questionsmedicales.fr/mesh/D024503?mesh_terms=Case-Control+Studies&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur bêta-Tocophérol", "description": "Quels sont les symptômes d'une carence en bêta-tocophérol ?\nLa carence en bêta-tocophérol cause-t-elle des problèmes de peau ?\nPeut-on avoir des troubles cognitifs à cause d'un déficit en bêta-tocophérol ?\nQuels signes neurologiques sont associés au bêta-tocophérol ?\nLa fatigue est-elle un symptôme d'une carence en bêta-tocophérol ?", "url": "https://questionsmedicales.fr/mesh/D024503?mesh_terms=Case-Control+Studies&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur bêta-Tocophérol", "description": "Comment prévenir une carence en bêta-tocophérol ?\nQuels conseils diététiques pour le bêta-tocophérol ?\nLes personnes âgées ont-elles besoin de plus de bêta-tocophérol ?\nLes végétariens doivent-ils surveiller leur bêta-tocophérol ?\nLes femmes enceintes ont-elles besoin de bêta-tocophérol ?", "url": "https://questionsmedicales.fr/mesh/D024503?mesh_terms=Case-Control+Studies&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur bêta-Tocophérol", "description": "Comment traiter une carence en bêta-tocophérol ?\nQuels aliments sont riches en bêta-tocophérol ?\nLes suppléments de bêta-tocophérol sont-ils sûrs ?\nQuelle est la posologie recommandée pour le bêta-tocophérol ?\nLe bêta-tocophérol peut-il interagir avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D024503?mesh_terms=Case-Control+Studies&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur bêta-Tocophérol", "description": "Quelles complications peuvent survenir avec une carence en bêta-tocophérol ?\nLa carence en bêta-tocophérol peut-elle affecter le système immunitaire ?\nDes maladies cardiovasculaires sont-elles liées au bêta-tocophérol ?\nLes troubles de la coagulation sont-ils liés au bêta-tocophérol ?\nLa carence en bêta-tocophérol peut-elle causer des problèmes de fertilité ?", "url": "https://questionsmedicales.fr/mesh/D024503?mesh_terms=Case-Control+Studies&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur bêta-Tocophérol", "description": "Quels sont les facteurs de risque de carence en bêta-tocophérol ?\nLes maladies digestives augmentent-elles le risque de carence ?\nLes personnes obèses sont-elles à risque de carence en bêta-tocophérol ?\nLes fumeurs ont-ils un risque accru de carence en bêta-tocophérol ?\nLes personnes âgées sont-elles plus à risque de carence ?", "url": "https://questionsmedicales.fr/mesh/D024503?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en bêta-tocophérol ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des analyses sanguines mesurant les niveaux de vitamine E." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer le bêta-tocophérol ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de dosage des lipides et des vitamines dans le sang sont couramment utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un déficit en bêta-tocophérol ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la faiblesse musculaire et des troubles neurologiques peuvent indiquer un déficit." } }, { "@type": "Question", "name": "Le bêta-tocophérol est-il mesuré dans les bilans de santé ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être inclus dans les bilans de santé pour évaluer l'état nutritionnel." } }, { "@type": "Question", "name": "Quels médecins peuvent diagnostiquer une carence en bêta-tocophérol ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les médecins généralistes et les nutritionnistes peuvent diagnostiquer cette carence." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une carence en bêta-tocophérol ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles de la vision, des problèmes neurologiques et une faiblesse musculaire." } }, { "@type": "Question", "name": "La carence en bêta-tocophérol cause-t-elle des problèmes de peau ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des problèmes cutanés comme la sécheresse et l'irritation." } }, { "@type": "Question", "name": "Peut-on avoir des troubles cognitifs à cause d'un déficit en bêta-tocophérol ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un déficit peut entraîner des troubles cognitifs et des problèmes de mémoire." } }, { "@type": "Question", "name": "Quels signes neurologiques sont associés au bêta-tocophérol ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des réflexes diminués et des troubles de la coordination peuvent apparaître." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme d'une carence en bêta-tocophérol ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue et la faiblesse générale peuvent être des symptômes de carence." } }, { "@type": "Question", "name": "Comment prévenir une carence en bêta-tocophérol ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en vitamine E et des suppléments si nécessaire aident à prévenir." } }, { "@type": "Question", "name": "Quels conseils diététiques pour le bêta-tocophérol ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Inclure des noix, des graines et des huiles végétales dans votre alimentation quotidienne." } }, { "@type": "Question", "name": "Les personnes âgées ont-elles besoin de plus de bêta-tocophérol ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir besoin de plus de bêta-tocophérol en raison de l'absorption réduite." } }, { "@type": "Question", "name": "Les végétariens doivent-ils surveiller leur bêta-tocophérol ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les végétariens doivent s'assurer d'inclure des sources de vitamine E dans leur régime." } }, { "@type": "Question", "name": "Les femmes enceintes ont-elles besoin de bêta-tocophérol ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le bêta-tocophérol est important pour le développement fœtal et la santé maternelle." } }, { "@type": "Question", "name": "Comment traiter une carence en bêta-tocophérol ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des suppléments de vitamine E et des modifications alimentaires." } }, { "@type": "Question", "name": "Quels aliments sont riches en bêta-tocophérol ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les huiles végétales, les noix et les légumes à feuilles vertes sont riches en bêta-tocophérol." } }, { "@type": "Question", "name": "Les suppléments de bêta-tocophérol sont-ils sûrs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "En général, ils sont sûrs, mais il est conseillé de consulter un médecin avant de commencer." } }, { "@type": "Question", "name": "Quelle est la posologie recommandée pour le bêta-tocophérol ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La posologie varie, mais généralement, 15 mg par jour est recommandé pour les adultes." } }, { "@type": "Question", "name": "Le bêta-tocophérol peut-il interagir avec d'autres médicaments ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut interagir avec des anticoagulants et d'autres médicaments, consultez un médecin." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une carence en bêta-tocophérol ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles neurologiques graves et des problèmes de vision." } }, { "@type": "Question", "name": "La carence en bêta-tocophérol peut-elle affecter le système immunitaire ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une carence peut affaiblir le système immunitaire, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Des maladies cardiovasculaires sont-elles liées au bêta-tocophérol ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une carence prolongée peut augmenter le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les troubles de la coagulation sont-ils liés au bêta-tocophérol ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une carence peut entraîner des troubles de la coagulation sanguine." } }, { "@type": "Question", "name": "La carence en bêta-tocophérol peut-elle causer des problèmes de fertilité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux insuffisants peuvent affecter la fertilité chez les hommes et les femmes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de carence en bêta-tocophérol ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent une alimentation pauvre, des troubles d'absorption et certaines maladies chroniques." } }, { "@type": "Question", "name": "Les maladies digestives augmentent-elles le risque de carence ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la maladie cœliaque peuvent réduire l'absorption de la vitamine E." } }, { "@type": "Question", "name": "Les personnes obèses sont-elles à risque de carence en bêta-tocophérol ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité peut affecter l'absorption des vitamines liposolubles comme le bêta-tocophérol." } }, { "@type": "Question", "name": "Les fumeurs ont-ils un risque accru de carence en bêta-tocophérol ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut augmenter le besoin en antioxydants, y compris le bêta-tocophérol." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque de carence ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'absorption des nutriments diminue souvent avec l'âge, augmentant le risque de carence." } } ] } ] }

Sources (10000 au total)

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev... A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus... Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);... The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...

Risk Factors for Postoperative Pneumonia: A Case-Control Study.

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ... A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch... Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent... Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ... www.chictr.org.cn, identifier: chiCTR2100045986....

Significance of temperature in antimuscarinic toxicity: a case-control study.

Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p... This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (... Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ... Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.

Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden... Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases... Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh... The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...

Anemia and Idiopathic Intracranial Hypertension: A Case-Control Study.

Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r... Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet... One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%... Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...

Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.

Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs.... Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor... Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant... Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...

Systemic hormone therapy and dementia: A nested case-control and co-twin control study.

The effect of systemic hormone therapy (HT) on dementia risk is unclear. Our aim was to investigate the association between HT and dementia.... This register-based study consists of a nested case-control study and a co-twin control design, which controls for familial confounding, including shared genetics.... Through Danish national registries from 1995 to 2011, we identified: a) 2700 female singletons with incident dementia and 13,492 matched controls; b) 288 female twins with incident dementia and co-twi... The odds ratio (OR) for the association between systemic HT and dementia was 1.05, 95% CI = [0.93-1.19] in singletons and 2.10, 95% CI = [0.99-4.46] in twins. A statistically significant association w... Using Danish nationwide registries and controlling for education and for familial factors in a subsample, systemic HT was found to be associated with increased dementia risk if used before 2003, when ...